This cross-sectional study examines whether a US Food and Drug Administration (FDA) boxed warning for montelukast was associated with changes in prescription rates of montelukast to treat asthma in the US.
Recent Posts
- Immigration Ban and the US Health Care Workforce
- Conceptual Questioning in Mathematics Teacher Education: Transforming Routine Questions
- Salutogenic Housing for Older Adults: The Role of Residential In-Between Spaces on the Environmental Sense of Coherence Among Older Adults (Tehran)
- Enhancing EFL Students’ Cognitive, Affective, and Conative Reading Attitudes: The Role of Task-Based Instruction
- Missing Disclaimer and Additional Information